Does the Frequency of Routine Follow-up After Curative Treatment for Head-and-neck Cancer Affect Survival?

Overview

Journal Curr Oncol

Publisher MDPI

Specialty Oncology

Date 2019 Nov 12

PMID 31708648

Citations 5

Authors

S F Hall

T Owen

R J Griffiths

K Brennan

Affiliations

Soon will be listed here.

Abstract

Background: Routine follow-up is a cornerstone of oncology practice, but evidence to support most aspects of follow-up is lacking. Our objective was to investigate the relationship between frequency of routine follow-up and survival.

Methods: This population-based study used electronic health care data relating to 5310 patients from Ontario diagnosed with squamous-cell head-and-neck cancer during 2007-2012. Treatments included surgery (24.6%), radiotherapy with or without chemotherapy (52.4%), and combined surgery and radiotherapy (23%). We determined the oncologist who was following each patient after treatment; calculated the average follow-up visits to the oncologist during the subsequent 2.5 years for all patients who were doing well; and used Kaplan-Meier and multiple variable regression analysis to compare, by treatment, overall survival for patients in the high, typical, and low follow-up oncologist groups.

Results: Many oncologists saw patients 40%-80% more often than other oncologists did. No relationship of appointment frequency with survival was observed for patients in any treatment group.

Conclusions: The practice of routine follow-up varies and is costly both to a health care system and to patients. Without evidence about the effectiveness of current policies, further research is required to investigate new or optimal practices.

Citing Articles

The Value of Surveillance Imaging of Oral Squamous Cell Carcinoma.

Bissinger O, Von den Hoff A, Maier E, Obermeier K, Stimmer H, Kolk A Cancers (Basel). 2024; 16(1).

PMID: 38201635 PMC: 10778242. DOI: 10.3390/cancers16010207.

Evaluation of a remote monitoring app in head and neck cancer follow-up care.

van de Weerd C, Ebbers T, Smilde D, van Tol-Geerdink J, Takes R, van den Broek G Cancer Med. 2023; 12(14):15552-15566.

PMID: 37293944 PMC: 10417106. DOI: 10.1002/cam4.6202.

Exploring the views of patients' and their family about patient-initiated follow-up in head and neck cancer: A mixed methods study.

Lorenc A, Greaves C, Duda J, Brett J, Matheson L, Fulton-Lieuw T Eur J Cancer Care (Engl). 2022; 31(6):e13641.

PMID: 35789510 PMC: 9787693. DOI: 10.1111/ecc.13641.

Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial.

Lorenc A, Wells M, Fulton-Lieuw T, Nankivell P, Mehanna H, Jepson M Clin Oncol (R Coll Radiol). 2021; 34(4):230-240.

PMID: 34862101 PMC: 8950325. DOI: 10.1016/j.clon.2021.11.010.

Actuarial Analysis of Survival among Breast Cancer Patients in Lithuania.

Skucaite A, Puvaciauskiene A, Puisys R, Siaulys J Healthcare (Basel). 2021; 9(4).

PMID: 33915700 PMC: 8066802. DOI: 10.3390/healthcare9040383.

References

Boysen M, Lovdal O, Tausjo J, WINTHER F . The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer. 1992; 28(2-3):426-30. DOI: 10.1016/s0959-8049(05)80068-1. View

WENNBERG J . Dealing with medical practice variations: a proposal for action. Health Aff (Millwood). 1984; 3(2):6-32. DOI: 10.1377/hlthaff.3.2.6. View

Roman B, Goldenberg D, Givi B . AHNS Series--Do you know your guidelines? Guideline recommended follow-up and surveillance of head and neck cancer survivors. Head Neck. 2015; 38(2):168-74. DOI: 10.1002/hed.24100. View

Brennan K, Hall S, Yoo J, Rohland S, Theurer J, Peng Y . Routine follow-up care after curative treatment of head and neck cancer: A survey of patients' needs and preferences for healthcare services. Eur J Cancer Care (Engl). 2019; 28(2):e12993. DOI: 10.1111/ecc.12993. View

Grunfeld E . Looking beyond survival: how are we looking at survivorship?. J Clin Oncol. 2006; 24(32):5166-9. DOI: 10.1200/JCO.2006.06.5953. View

Brennan K, Hall S, Owen T, Griffiths R, Peng Y . Variation in routine follow-up care after curative treatment for head-and-neck cancer: a population-based study in Ontario. Curr Oncol. 2018; 25(2):e120-e131. PMC: 5927791. DOI: 10.3747/co.25.3892. View

Cooney T, Poulsen M . Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer?. Arch Otolaryngol Head Neck Surg. 1999; 125(4):379-82. DOI: 10.1001/archotol.125.4.379. View

Austin P, Stanbrook M, Anderson G, Newman A, Gershon A . Comparative ability of comorbidity classification methods for administrative data to predict outcomes in patients with chronic obstructive pulmonary disease. Ann Epidemiol. 2012; 22(12):881-7. PMC: 4617831. DOI: 10.1016/j.annepidem.2012.09.011. View

Ritoe S, Krabbe P, Kaanders J, van den Hoogen F, Verbeek A, Marres H . Value of routine follow-up for patients cured of laryngeal carcinoma. Cancer. 2004; 101(6):1382-9. DOI: 10.1002/cncr.20536. View

10.

Brewer N, Borman B, Sarfati D, Jeffreys M, Fleming S, Cheng S . Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort study. BMC Cancer. 2011; 11:132. PMC: 3087712. DOI: 10.1186/1471-2407-11-132. View

11.

Gupta S, Kong W, Peng Y, Miao Q, Mackillop W . Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States. Int J Cancer. 2009; 125(9):2159-65. DOI: 10.1002/ijc.24533. View

12.

Flynn C, Khaouam N, Gardner S, Higgins K, Enepekides D, Balogh J . The value of periodic follow-up in the detection of recurrences after radical treatment in locally advanced head and neck cancer. Clin Oncol (R Coll Radiol). 2010; 22(10):868-73. DOI: 10.1016/j.clon.2010.05.016. View

13.

Morton R, Hay K, Macann A . On completion of curative treatment of head and neck cancer: why follow up?. Curr Opin Otolaryngol Head Neck Surg. 2004; 12(2):142-6. DOI: 10.1097/00020840-200404000-00015. View

14.

Cohen E, LaMonte S, Erb N, Beckman K, Sadeghi N, Hutcheson K . American Cancer Society Head and Neck Cancer Survivorship Care Guideline. CA Cancer J Clin. 2016; 66(3):203-39. DOI: 10.3322/caac.21343. View

15.

Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J . Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005; 43(11):1130-9. DOI: 10.1097/01.mlr.0000182534.19832.83. View

16.

Manikantan K, Khode S, Dwivedi R, Palav R, Nutting C, Rhys-Evans P . Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up. Cancer Treat Rev. 2009; 35(8):744-53. DOI: 10.1016/j.ctrv.2009.08.007. View

17.

Francis D, Yueh B, Weymuller Jr E, Merati A . Impact of surveillance on survival after laryngeal cancer in the medicare population. Laryngoscope. 2009; 119(12):2337-44. DOI: 10.1002/lary.20576. View

18.

Kazi R, Manikanthan K, Pathak K, Dwivedi R . Head and neck squamous cell cancers: need for an organised time-bound surveillance plan. Eur Arch Otorhinolaryngol. 2010; 267(12):1969-71. DOI: 10.1007/s00405-010-1377-x. View

19.

Hall S, Griffiths R . Evaluation of treatment outcomes in patients with supraglottic laryngeal cancer in Ontario, Canada: A population-based study. Head Neck. 2018; 40(5):1024-1033. DOI: 10.1002/hed.25073. View

20.

Lester S, Wight R . 'When will I see you again?' Using local recurrence data to develop a regimen for routine surveillance in post-treatment head and neck cancer patients. Clin Otolaryngol. 2010; 34(6):546-51. DOI: 10.1111/j.1749-4486.2009.02033.x. View